-
Being under ever-increasing pressure to compete in a challenging economic and technological environment, pharmaceutical and biotech companies must continually innovate in their R&D programmes to stay ahead of the game. External innovations come in different forms and originate in diffe...阅读更多»
-
据发表在细胞的研究中,研究人员已经开发了KRASG12C的特异性抑制剂名为诱发肿瘤消退的小鼠ARS-1602。 “这项研究在体内的证据提供了KRAS突变可以选择性地靶向,揭示ARS-1620为代表的......新一代阅读更多»
-
阿斯利康公司收到其肿瘤产品组合的双重提振,周二,因美国和欧洲监管机构接受的监管机构提交申请为其药品,向获奖批准这些药物的第一步。 盎格鲁-瑞典制药商MedImmune公司和其全球生物制品研究和德... 阅读更多»